Selskabets formål er at udvikle nye terapeutiske behandlinger for hjernesygdomme samt relaterede aktiviteter.
CVR: 46215621
Mette Marie Rosenkilde joined as director
Maria Gundersen Deslauriers joined as director
Katrine Møller Qvortrup joined as director
MM Rosenkilde ApS registered with 33% ownership
Børgefjell ApS registered with 33% ownership
KaQvo Holding ApS registered with 33% ownership
was founded
Companies in the same industry and area